<DOC>
	<DOCNO>NCT02182856</DOCNO>
	<brief_summary>Study compare effect nebulised salbutamol ipratropium alone patient COPD combine salbutamol ipratropium nebuliser solution arterial oxygen saturation ( SaO2 ) characterise patient COPD ( chronic obstructive pulmonary disease ) risk significant arterial oxygen desaturation follow nebulised salbutamol .</brief_summary>
	<brief_title>Ipratropium Salbutamol Sulphate Alone Combination Therapy Salbutamol Ipratropium Patients With COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>Male female patient moderate severe stable COPD : Patients diagnosis chronic bronchitis and/or emphysema FEV1 &lt; 65 % predict value without regard prior treatment Forced expiratory ration ( FER = FEV1/VC ) &lt; 70 % predict value without regard prior treatment Patients must respiratory infection exacerbation COPD four week immediately prior enter trial Patients must change normal treatment COPD four week immediately prior enter trial Patient age ≥40 year Patients smoke history ≥15 packyears Patients must give informed consent participate trial Patients diagnosis asthma , bronchiectasis , cystic fibrosis bronchiolitis obliterans Patients follow : untreated angle closure glaucoma hypertrophic obstructive cardiomyopathy tachyarrhythmia recent myocardial infarction ( within six month screen visit ) severe organic cardiac vascular disorder untreated hyperthyroidism diabetes mellitus ( approval Protocol Amendment 1 , inclusion well control diabetic patient allow ) Patients pregnant , planning pregnancy , nurse mother Patients know hypersensitive anticholinergic drug β2 agonist Patients know abuse drug alcohol Patients , opinion investigator , likely cooperate requirement trial Patients PaO2 ( arterial carbon dioxide tension ) &lt; 56 mmHg ( 7.5 kPa ) rest breathe air without regard prior treatment Patients SaO2 ≤85 % rest breathe air without regard prior treatment Patients take part another investigation , patient participate another clinical trial three month immediately precede entry trial Patients home oxygen concentrator therapy Patients previously participate randomised phase trial</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>